Expression of Concern:“Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.”(Int. J. Cancer, (2009), 125, 5, (1038-44), 10.1002/ijc.24372);Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells

International Journal of Cancer

Volumn 125, Issue 5, 2009, Pages 1038-1044

  Terrasi, Marianna ^a,b   Fiorio, Elena ^a,c   Mercanti, Anna ^a,c   Koda, Mariusz ^d   Moncada, Camilo A ^e   Sulkowski, Stanislaw ^d   Merali, Salim ^e   Russo, Antonio ^b   Surmacz, Eva ^a  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Insulin; Leptin; Nucleolin; Polymorphism; Sp1

Indexed keywords

LEPTIN; MESSENGER RNA; NUCLEOLIN; PROTEIN C JUN; TRANSCRIPTION FACTOR SP1;

ADIPOCYTE; ADULT; AGED; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; DOWN REGULATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN TREATMENT; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

EID: 67650070739     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.33275     Document Type: Erratum

References (38)

1. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143:293-311.
2. Han C, Zhang HT, Du L, Liu X, Jing J, Zhao X, Yang X, Tian B. Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 2005;26:19-24.
3. Surmacz E. Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 2007;9:301.
4. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207:12-22.
5. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007;14:189-206.
6. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004;10:4325-31.
7. Koda M, Sulkowska M, Kanczuga-Koda L, Cascio S, Colucci G, Russo A, Surmacz E, Sulkowski S. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1alpha in human colorectal cancer. Ann Oncol 2007;18 (Suppl 6):vi116-9.
8. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, Noguchi S. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006;118:1414-9.
9. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006;12:1447-53.
10. Zhao L, Shen ZX, Luo HS, Shen L. Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol 2005;11:7666-70.
11. Yuan SS, Chung YF, Chen HW, Tsai KB, Chang HL, Huang CH, Su JH. Aberrant expression and possible involvement of the leptin receptor in bladder cancer. Urology 2004;63:408-13.
12. Laud K, Gourdou I, Pessemesse L, Peyrat JP, Djiane J. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002;188:219-26.
13. Koda M, Sulkowska M, Wincewicz A, Kanczuga-Koda L, Musiatowicz B, Szymanska M, Sulkowski S. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci 2007;1095:90-8.
14. Cascio S, Bartella V, Auriemma A, Johannes GJ, Russo A, Giordano A, Surmacz E. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. Oncogene 2008;27:540-7.
15. Mammes O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F. Novel polymorphisms in the 50 region of the LEP gene: association with leptin levels and response to lowcalorie diet in human obesity. Diabetes 1998;47:487-9.
16. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 2000;64:391-4.
17. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34: 355-9.
18. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Hegedus C, Smith MT. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:779-86.
19. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004;59:268-74.
20. Ribeiro R, Araujo AP, Coelho A, Catarino R, Pinto D, Araujo A, Calcada C, Lopes C, Medeiros R. A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 2006;42:1188-93.
21. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006;6:38.
22. Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem 1996; 271:3971-4.
23. Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E. Insulin-dependent leptin expression in breast cancer cells. Cancer Res 2008;68:4919-27.
24. Tsou JH, Chang KY, Wang WC, Tseng JT, Su WC, Hung LY, Chang WC, Chen BK. Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells. Nucleic Acids Res 2008;36:217-27.
25. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M, Huh NH. S100C/A11 is a key mediator of Ca(21)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 2003;163:825-35.
26. Ginisty H, Amalric F, Bouvet P. Nucleolin functions in the first step of ribosomal RNA processing. EMBO J 1998;17:1476-86.
27. Erard M, Lakhdar-Ghazal F, Amalric F. Repeat peptide motifs which contain beta-turns and modulate DNA condensation in chromatin. Eur J Biochem 1990;191:19-26.
28. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007;17:80-6.
29. Csermely P, Schnaider T, Cheatham B, Olson MO, Kahn CR. Insulin induces the phosphorylation of nucleolin. A possible mechanism of insulin-induced. RNA efflux from nuclei. J Biol Chem 1993;268: 9747-52.
30. Morelli C, Garofalo C, Bartucci M, Surmacz E. Estrogen receptoralpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 2003;22:4007-16.
31. Morelli C, Garofalo C, Sisci D, del Rincon S, Cascio S, Tu X, Vecchione A, Sauter ER, Miller WH, Jr, Surmacz E. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 2004;23:7517-26.
32. Cascio S, Bartella V, Garofalo C, Russo A, Giordano A, Surmacz E. Insulin-like growth factor 1 differentially regulates estrogen receptordependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 2007;282:3498-506.
33. Revillion F, Charlier M, Lhotellier V, Hornez L, Giard S, Baranzelli MC, Djiane J, Peyrat JP. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 2006;12:2088-94.
34. Cascio S, Bartella V, Auriemma A, Johannes GJ, Russo A, Giordano A, Surmacz E. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. Oncogene 2008;27: 540-7.
35. Clarke RFL, Brunner N, Thompson EW. In vitro model of breast cancer. In: Harris JR, Lippman ML, Morrow M, Hellman S, editors. Diseases of breast. Philadelphia: Lippincott-Raven, 1996.
36. Meissner U, Ostreicher I, Allabauer I, Rascher W, Dotsch J. Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun 2003;303:707-12.
37. Belfiore A, Frasca F. IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008;13:381-406.
38. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-28.